Remodulin and Macitentan drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Remodulin (treprostinil sodium) and Macitentan (macitentan). Common drug interactions include decreased appetite among females and infusion site pain among males.
The phase IV clinical study analyzes what interactions people have when they take Remodulin and Macitentan. It is created by eHealthMe based on reports of 604 people who take the same drugs from the FDA, and is updated regularly.
What is Remodulin?
Remodulin has active ingredients of treprostinil sodium. It is often used in primary pulmonary hypertension. eHealthMe is studying from 55,843 Remodulin users. Check the latest studies of Remodulin.
What is Macitentan?
Macitentan has active ingredients of macitentan. eHealthMe is studying from 7,371 Macitentan users. Check the latest studies of Macitentan.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
604 people who take Remodulin and Macitentan together, and have interactions are studied.
What are the common drug interactions of Remodulin and Macitentan, by gender? *
What are the common drug interactions of Remodulin and Macitentan, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Remodulin and Macitentan?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Remodulin (55,843 reports)
- Macitentan (7,371 reports)
Browse all drug interactions of Remodulin and Macitentan:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Remodulin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Macitentan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Remodulin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Macitentan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on treprostinil sodium and macitentan (the active ingredients of Remodulin and Macitentan, respectively), and Remodulin and Macitentan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Hypercalcaemia Of Malignancy and Fever - 11 seconds ago
- Verelan vs. Benicar, side effect and effectiveness comparison - 45 seconds ago
- Could Cetirizine Hydrochloride cause Exostosis? - 59 seconds ago
- Could Letrozole cause Pelvic Discomfort? - a minute ago
- Could Stelara cause Pleural Effusion? - a minute ago
- Could Prednisone cause Fear Of Disease? - 2 minutes ago
- Could Metoprolol Succinate cause Obstruction Gastric? - 2 minutes ago
- Could Miralax cause Joint Pain? - 2 minutes ago
- Synephrine and Amoxicillin drug interactions for men aged 50-59 - 2 minutes ago
- Could Xyrem cause Complex Partial Seizures? - 2 minutes ago